ScienceDex / Researcher record
Didsbury, John
- T3d Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,545
- Sustained Excellence
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2019 | $2,292,799 | 1 | #2,540 |
| 2020 | $3,102,477 | 1 | #401 |
| 2021 | $5,526,539 | 1 | #601 |
| 2022 | $8,135,575 | 3 | #326 |
| 2023 | $1,779,116 | 2 | #4,545 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20191 record
- FY20201 record
- FY20211 record
- FY20223 records
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Didsbury, John as a PI. Multi-PI records show the full award amount for context.
- 1R44AG082580-01R44Contact PIClinical Development Enablement – Long Term Rodent Testing of the Carcinogenic Potential of the Alzheimer’s Disease Drug Candidate T3D-959$1.2Maward amount
- 5R44NS127671-02R44Contact PIPhase 2 Enabling Studies of a Candidate Drug Therapy (T3D-959) Regulating Neurometabolism for the Treatment of Huntington's Disease$529.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Didsbury, John as a PI.
FY2023 award administered by T3d Therapeutics, Inc. (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardT3d Therapeutics, Inc.
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #2540
- 2019Entered Top 25% NationallyRanked #2540
- 2020$5M Cumulative Funding
- 2020Entered Top 10% NationallyRanked #401
- 2020Entered Top 5% NationallyRanked #401
- 2021$10M Cumulative Funding